University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients

Completed

Conditions: Asthma in Children
Asthma Attack
Asthma Acute
Asthma Chronic

First Posted Date: 2018-08-22

Last Posted Date: 2020-07-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT03642418

Locations: 🇺🇸
UCSF- Benioff Children Hospital, San Francisco, California, United States

Metformin for Pulmonary Hypertension HFpEF

Phase 2

Recruiting

Conditions: Heart Failure
Pulmonary Hypertension

Interventions: Drug: Placebo oral capsule
Drug: Metformin

First Posted Date: 2018-08-14

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT03629340

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Phase 4

Completed

Conditions: Hepatitis C
Transplantation Disease Transmission

Interventions: Drug: Sofosbuvir/Velpatasvir
Drug: Sofosbuvir/Velpatasvir/Voxilaprevir

First Posted Date: 2018-08-08

Last Posted Date: 2021-03-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 122

Registration Number: NCT03619837

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Baylor University Medical Center - Dallas, Dallas, Texas, United States
🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

and more 3 locations

Addressing Social Vulnerabilities in Cardiovascular Disease

Not Applicable

Conditions: Acute Myocardial Infarction
Ischemic Heart Disease
Coronary Artery Disease
Congestive Heart Failure

Interventions: Other: Socially Enhanced Transitional Care Intervention

First Posted Date: 2018-08-02

Last Posted Date: 2021-06-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 50

Registration Number: NCT03613064

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

Completed

Conditions: Immune Deficiency
Thalassemia
Hemoglobinopathies
Fanconi Anemia
Sickle Cell Disease
Nonmalignant Diseases
Hematologic Malignancies
Genetic Inborn Errors of Metabolism

Interventions: Drug: Thiotepa

First Posted Date: 2018-08-01

Last Posted Date: 2023-09-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 25

Registration Number: NCT03609840

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

Completed

Conditions: Hemoglobinopathies
Nonmalignant Diseases
Immunodeficiencies
Sickle Cell Disease
Hematologic Malignancies
Genetic Inborn Errors of Metabolism
Thalassemia
Fanconi's Anemia

Interventions: Drug: Clofarabine
Drug: Fludarabine Injection

First Posted Date: 2018-08-01

Last Posted Date: 2021-10-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT03609814

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

Completed

Conditions: Hematologic Malignancies
Thalassemia
Hemoglobinopathies
Fanconi's Anemia
Nonmalignant Diseases
Immunodeficiencies
Genetic Inborn Errors of Metabolism
Sickle Cell Disease

Interventions: Drug: Melphalan

First Posted Date: 2018-08-01

Last Posted Date: 2021-10-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 25

Registration Number: NCT03609827

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Evaluating the Impact of the National Health Insurance Scheme of Ghana on Surgical Care

Completed

Conditions: General Surgery, Costs and Cost Analysis

First Posted Date: 2018-07-27

Last Posted Date: 2018-07-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 203

Registration Number: NCT03604458

Locations: 🇬🇭
Korle-Bu Teaching Hospital, Accra, Ghana

Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients

Not Applicable

Completed

Conditions: Lower Extremity Amputation

Interventions: Other: Lower Extremity Amputation Pathway

First Posted Date: 2018-07-19

Last Posted Date: 2021-02-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 11

Registration Number: NCT03592316

Locations: 🇺🇸
Community Regional Medical Center, Fresno, California, United States

Arterial Imaging of Inflammation and Resolution After Endovascular Surgery

Phase 1

Completed

Conditions: Iliac Artery Disease
Claudication, Intermittent
PAD
Peripheral Arterial Disease
Claudication
SFA - Superficial Femoral Artery Stenosis
Vascular Calcification

Interventions: Drug: 18F-FDG

First Posted Date: 2018-07-18

Last Posted Date: 2020-11-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 9

Registration Number: NCT03590769

Locations: 🇺🇸
UCSF, San Francisco, California, United States
🇺🇸
San Francisco General Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy